Literature DB >> 15349899

Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells.

Hideki Yokoo1, Tadashi Kondo, Kazuyasu Fujii, Tesshi Yamada, Satoru Todo, Setsuo Hirohashi.   

Abstract

Alpha fetoprotein (AFP) has been implicated in the development of hepatocellular carcinoma and is considered to be a diagnostic and prognostic tumor marker. Because elevated expression of AFP is associated with many characteristics of hepatocellular carcinoma tissues, we hypothesized that multiple proteins may function in a coordinated manner with AFP. To identify such proteins, we performed global protein expression analysis, namely a proteomic study. The protein expression profiles of 9 AFP-producing liver cancer cell lines (JHH-5, HuH-1, PLC/PRL/5, Hep3B, HT-17, JHH-7, HuH-7, HepG2, Li-7) and 7 nonproducing liver cancer cell lines (HLE, JHH-6, Sk-Hep-1, JHH-4, HLF, RBE, SSP-25) were generated by fluorescence 2-dimensional difference gel electrophoresis. In fluorescence 2-dimensional difference gel electrophoresis, proteins are labeled with fluorescent dyes before electrophoresis for more accurate quantitative expression analysis. We identified 11 protein spots that distinguished AFP-producing cell lines from nonproducing cell lines by multivariate studies. The spots showed consistent alterations in amount in AFP-producing cell lines (6 up-regulated and 5 down-regulated). An additional 5 liver cancer cell lines (KIM-1, KYN-2, KYN-3, PH5-CH, PH5-T) also were correctly grouped with respect to their AFP production on the basis of the intensity of the 11 protein spots. The proteins corresponding to the 11 selected spots were identified by mass spectrometry and were categorized into 4 groups based on their known role in apoptosis, glucose metabolism, cytoskeletal organization, or translation. In conclusion, we found a novel association of AFP with other proteins. Their interaction should provide insight into the biology of AFP-producing hepatocellular carcinoma cells. Copyright 2004 American Association for the Study of Liver Diseases

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15349899     DOI: 10.1002/hep.20372

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  20 in total

Review 1.  Glycosylation and liver cancer.

Authors:  Anand Mehta; Harmin Herrera; Timothy Block
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

Review 2.  Proteomic analysis in cancer research: potential application in clinical use.

Authors:  Jesús García-Foncillas; Eva Bandrés; Ruth Zárate; Natalia Remírez
Journal:  Clin Transl Oncol       Date:  2006-04       Impact factor: 3.405

Review 3.  Proteomic approaches to analyzing hepatitis C virus biology.

Authors:  Florian Douam; Alexander Ploss
Journal:  Proteomics       Date:  2015-05-05       Impact factor: 3.984

4.  Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures.

Authors:  Alexander Ploss; Salman R Khetani; Christopher T Jones; Andrew J Syder; Kartik Trehan; Valeriya A Gaysinskaya; Kathy Mu; Kimberly Ritola; Charles M Rice; Sangeeta N Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

5.  Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation.

Authors:  Zheng-Hua Lu; Feng Shen; Zhen-Lin Yan; Jun Li; Jia-He Yang; Ming Zong; Le-Hua Shi; Meng-Chao Wu
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-26       Impact factor: 4.553

6.  Pioglitazone decreases hepatitis C viral load in overweight, treatment naïve, genotype 4 infected-patients: a pilot study.

Authors:  Mario Chojkier; Hisham Elkhayat; Dina Sabry; Michael Donohue; Martina Buck
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

7.  Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens.

Authors:  Sandra March; Vyas Ramanan; Kartik Trehan; Shengyong Ng; Ani Galstian; Nil Gural; Margaret A Scull; Amir Shlomai; Maria M Mota; Heather E Fleming; Salman R Khetani; Charles M Rice; Sangeeta N Bhatia
Journal:  Nat Protoc       Date:  2015-11-19       Impact factor: 13.491

8.  A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax.

Authors:  Sandra March; Shengyong Ng; Soundarapandian Velmurugan; Ani Galstian; Jing Shan; David J Logan; Anne E Carpenter; David Thomas; B Kim Lee Sim; Maria M Mota; Stephen L Hoffman; Sangeeta N Bhatia
Journal:  Cell Host Microbe       Date:  2013-07-17       Impact factor: 21.023

Review 9.  Biomarkers for hepatocellular carcinoma based on body fluids and feces.

Authors:  Ming-Cheng Guan; Wei Ouyang; Ming-Da Wang; Lei Liang; Na Li; Ting-Ting Fu; Feng Shen; Wan-Yee Lau; Qiu-Ran Xu; Dong-Sheng Huang; Hong Zhu; Tian Yang
Journal:  World J Gastrointest Oncol       Date:  2021-05-15

10.  Rapidly progressive hepatocellular carcinoma mimicking benign portal vein thrombosis: a case report.

Authors:  Jin Woong Kim; Byung Chan Lee; Sang Soo Shin; Suk Hee Heo; Hyo Soon Lim; Yong Yeon Jeong; Heoung Keun Kang; Young Hoe Hur; Yoo Duk Choi
Journal:  Gut Liver       Date:  2013-01-11       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.